Use of nanoparticles in animal models for prostate cancer treatment: a systematic review
Open Access
- 1 January 2023
- journal article
- review article
- Published by FapUNIFESP (SciELO) in Acta Cirurgica Brasileira
- Vol. 38, e385923
Abstract
To conduct a systematic review of nanoparticles’ use in the treatment of prostate cancer in animals.Keywords
This publication has 25 references indexed in Scilit:
- Nanoparticles in the clinicBioengineering & Translational Medicine, 2016
- Docetaxel–carboxymethylcellulose nanoparticles display enhanced anti-tumor activity in murine models of castration-resistant prostate cancerInternational Journal of Pharmaceutics, 2014
- Carboxymethylcellulose-Based and Docetaxel-Loaded Nanoparticles Circumvent P-Glycoprotein-Mediated Multidrug ResistanceMolecular Pharmaceutics, 2014
- Micellar Delivery of Flutamide Via Milk Protein Nanovehicles Enhances its Anti-Tumor Efficacy in Androgen-Dependent Prostate Cancer Rat ModelPharmaceutical Research, 2013
- Cellular uptake, antitumor response and tumor penetration of cisplatin-loaded milk protein nanoparticlesBiomaterials, 2013
- A docetaxel-carboxymethylcellulose nanoparticle outperforms the approved taxane nanoformulation, Abraxane, in mouse tumor models with significant control of metastasesJournal of Controlled Release, 2012
- Developing a Highly Stable PLGA-mPEG Nanoparticle Loaded with Cisplatin for Chemotherapy of Ovarian CancerPLOS ONE, 2011
- Properties and effects of a novel liquid crystal nanoparticle formulation of docetaxel in a prostate cancer mouse modelEuropean Journal of Pharmaceutical Sciences, 2010
- Soluble Polymer Carriers for the Treatment of Cancer: The Importance of Molecular ArchitectureAccounts of Chemical Research, 2009
- The basics of preclinical drug development for neurodegenerative disease indicationsBMC Neurology, 2009